BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16999655)

  • 1. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of a possible interaction between warfarin and levofloxacin.
    McCall KL; Scott JC; Anderson HG
    Pharmacotherapy; 2005 Jan; 25(1):67-73. PubMed ID: 15767222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
    Mohr JF; McKinnon PS; Peymann PJ; Kenton I; Septimus E; Okhuysen PC
    Pharmacotherapy; 2005 Oct; 25(10):1303-9. PubMed ID: 16185173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.
    Phillips EM; Buchan DA; Newman N; Rajan A; Zia S
    Pharmacotherapy; 2005 Oct; 25(10):1341-7. PubMed ID: 16185178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy.
    Yamreudeewong W; Lower DL; Kilpatrick DM; Enlow AM; Burrows MM; Greenwood MC
    Pharmacotherapy; 2003 Mar; 23(3):333-8. PubMed ID: 12627932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens.
    Glasheen JJ; Fugit RV; Prochazka AV
    J Gen Intern Med; 2005 Jul; 20(7):653-6. PubMed ID: 16050864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective and prospective analyses of the treatment of overanticoagulated patients.
    Duong TM; Plowman BK; Morreale AP; Janetzky K
    Pharmacotherapy; 1998; 18(6):1264-70. PubMed ID: 9855325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin and warfarin interaction.
    Jones CB; Fugate SE
    Ann Pharmacother; 2002 Oct; 36(10):1554-7. PubMed ID: 12243605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy.
    Raebel MA; Witt DM; Carroll NM; Magid DJ
    Pharmacotherapy; 2005 Aug; 25(8):1055-61. PubMed ID: 16207095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study.
    Graumlich JF; Habis S; Avelino RR; Salverson SM; Gaddamanugu M; Jamma K; Aldag JC
    Pharmacotherapy; 2005 Oct; 25(10):1296-302. PubMed ID: 16185172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
    Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
    Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation.
    Jackson SL; Peterson GM; Vial JH; Jupe DM
    J Intern Med; 2004 Aug; 256(2):137-44. PubMed ID: 15257726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.
    Witt DM; Sadler MA; Shanahan RL; Mazzoli G; Tillman DJ
    Chest; 2005 May; 127(5):1515-22. PubMed ID: 15888822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective evaluation of a potential interaction between azithromycine and warfarin in patients stabilized on warfarin.
    Beckey NP; Parra D; Colon A
    Pharmacotherapy; 2000 Sep; 20(9):1055-9. PubMed ID: 10999497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of warfarin initiation regimens in elderly inpatients.
    O'Connell MB; Kowal PR; Allivato CJ; Repka TL
    Pharmacotherapy; 2000 Aug; 20(8):923-30. PubMed ID: 10939553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative treatment of overanticoagulated patients.
    Glover JJ; Morrill GB
    Chest; 1995 Oct; 108(4):987-90. PubMed ID: 7555174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependency rather than old age increases the risk of warfarin-related bleeding.
    Goudie BM; Donnan PT; Fairfield G; Al-Agilly SS; Cachia PG
    Br J Gen Pract; 2004 Sep; 54(506):690-2. PubMed ID: 15353056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.
    Patel RJ; Witt DM; Saseen JJ; Tillman DJ; Wilkinson DS
    Pharmacotherapy; 2000 Oct; 20(10):1159-66. PubMed ID: 11034038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Warfarin Home INR Monitoring vs Office-Based Monitoring: a Retrospective Claims-Based Analysis.
    Van Beek A; Moeyaert M; Ragheb B; Price E; MacEwan JP; Ahmed N; Ansell J
    J Gen Intern Med; 2024 May; 39(7):1127-1134. PubMed ID: 38100006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.